Edition:
United States

Genera Biosystems Ltd (GBI.AX)

GBI.AX on Australia Stock Exchange

0.16AUD
--
Change (% chg)

-- (--)
Prev Close
$0.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
32,956
52-wk High
$0.31
52-wk Low
$0.12

Latest Key Developments (Source: Significant Developments)

Genera Biosystems Ltd says FY net loss for period attributable $3.1 million
Wednesday, 30 Aug 2017 11:30pm EDT 

Aug 31 (Reuters) - Genera Biosystems Ltd :FY revenue from ordinary activities $800,935, up 30.1%.FY net loss for period attributable $3.1 million versus loss of $3.1 million.  Full Article

Genera Biosystems announces amendment to series B convertible notes
Sunday, 2 Apr 2017 09:01pm EDT 

Genera Biosystems Ltd : Holders of 91.3% of all series b notes on issue by value, agreed to enter into variation amending terms of existing series b convertible notes .Under amended terms series B redemption date will be extended from current redemption date of 31 march 2017 until 30 June 2017.  Full Article

Genera Biosystems announces amendment to series B convertible notes
Sunday, 2 Apr 2017 07:28pm EDT 

Genera Biosystems Ltd : Holders of 91.3% of all series b notes on issue by value, agreed to enter into variation amending terms of existing series b convertible notes .Under amended terms series B redemption date will be extended from current redemption date of 31 march 2017 until 30 June 2017.  Full Article

Genera Biosystems receives approval for respiratory tract test in India
Monday, 20 Jun 2016 07:47pm EDT 

Genera Biosystems Ltd : Indian central drugs standard organisation approved importation and sale of genera's upper respiratory tract multiplex molecular diagnostics .Says license approval is in force for a term of 3 years to June 2019.  Full Article

BRIEF-Genera Biosystems announces amendment to series B convertible notes

* Holders of 91.3% of all series b notes on issue by value, agreed to enter into variation amending terms of existing series b convertible notes

No consensus analysis data available.